Corporate & Marketing Strategy 

Maximize the Organization’s or Product’s Potential.

    Drive ongoing value creation

    A strong corporate strategy is essential for successfully commercializing a drug and managing it throughout the product life cycle. Through our combination of advisory and functional services, we support manufacturers’ strategies through the development, commercialization, post-launch, and maturity phases.

    Our Corporate & Marketing Strategy Solutions

    Opportunity Assessment

    Before launching a new product, it’s important to understand the market dynamics, unmet needs, and how customers might respond. We provide details around potential positioning, estimated adoption rate, pricing scenarios, reimbursement potential, and peak sales forecast. 

    Brand Strategy Development

    Brand plans are a compilation and distillation of the organization’s knowledge of the marketplace. Understanding what the secondary and primary research really means, key implications, and what actions to take is paramount to your brand’s successful launch. 

    Launch Planning & Management

    Each launch is as unique as the drug itself, and needs a customized plan that includes all functional areas–such as marketing, clinical development, regulatory affairs, medical affairs, sales, market access, supply chain and operations—to keep teams on track for a successful launch.

    Go-To-Market Model

    We help manufacturers design the commercial model required to effectively bring their product to market, as well as identify disruptive approaches to commercialization.

    Staff Augmentation

    Our highly-skilled consulting team can serve as interim full-time equivalents to support functional departments within established or growing organizations.

    Diligence & Valuation

    We have tremendous experience completing in- and out-licensing evaluations of biopharma assets and individual service providers for private equity and venture capital firms in addition to optimizing the operations of individual portfolio companies.

    Let’s Get Started.

    Go to Top